SEPTInvestingStart Free

INM SCHEDULE 13G: SEC filing

Deep Track Capital, LP and affiliated entities

Filed with the SEC on · accession 0001172661-26-005030

INM filed a SCHEDULE 13G (schedule 13g) with the SEC on Nov 13, 2026. A report the company filed with the SEC (the US market regulator).

Summary of the filing

Deep Track Capital, LP and affiliated entities filed a Schedule 13G disclosing beneficial ownership of 2,977,478 shares (5.64%) of Mentari Therapeutics, Inc. (formerly InMed Pharmaceuticals), a passive investment position.

For details, click here →

Key details

Shares beneficially owned by Deep Track Capital, LP$3.0M
Shares beneficially owned by Deep Track Biotechnology Master Fund, Ltd.$2.2M
Shares beneficially owned by Deep Track Special Opportunities Fund, LP$763K
Reporting person / beneficial ownerDeep Track Capital, LP
Reporting person / beneficial owner of 2,214,135 shares (4.19%)Deep Track Biotechnology Master Fund, Ltd.
Reporting person / beneficial owner of 763,343 shares (1.45%)Deep Track Special Opportunities Fund, LP
Issuer / subject companyMentari Therapeutics, Inc. (InMed Pharmaceuticals Inc.)
Managing member of the general partner of deep track capital, lpDavid Kroin

✦ Ask GOAX AI about this filing — what it means for INM, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for INM?

Click here

Frequently asked questions

What did INM file with the SEC on Nov 13, 2026?

INM filed a SCHEDULE 13G (SEC filing). Deep Track Capital, LP and affiliated entities filed a Schedule 13G disclosing beneficial ownership of 2,977,478 shares (5.64%) of Mentari Therapeutics, Inc. (formerly InMed Pharmaceuticals), a passive investment position.

How do I read a SCHEDULE 13G?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).

Other INM SEC filings

Get alerts when INM files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
INM overviewINM analysisINM newsLatest SEC filings